Evidence map›Paper›PMID 37753462›Full record

ArticleClinical and translational radiation oncology2023

Considerations for intensity modulated total body or total marrow and lymphoid irradiation.

David Parsons, Tze Yee Lim, Jose R Teruel, Paulina Galavis, Stefano Agostinelli, Jieming Liang, Pietro Mancosu, Amanda Cherpak, Dennis N Stanley, Kang-Hyun Ahn and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and translational radiation oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

David ParsonsDepartment of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Tze Yee LimDepartment of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Jose R TeruelDepartment of Radiation Oncology, New York University Langone Health, New York, NY, USA.
Paulina GalavisDepartment of Radiation Oncology, New York University Langone Health, New York, NY, USA.
Stefano AgostinelliIRCCS Ospedale Policlinico San Martino, Genova, Italy.
Jieming LiangDepartment of Radiation Oncology, City of Hope National Medical Center City of Hope National Medical Center, Duarte, CA, USA.
Pietro MancosuIRCCS Humanitas Research Hospital, Medical Physics Unit, Rozzano, Milan, Italy.
Amanda CherpakDepartment of Radiation Oncology and Department of Medical Physics, Nova Scotia Health, Halifax, Nova Scotia, Canada.
Dennis N StanleyDepartment of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, USA.
Kang-Hyun AhnDepartment of Radiation Oncology, University of Illinois, Chicago, IL and Radiation and Cellular Oncology, University of Chicago, Chicago, IL, USA.
Bingqi GuoDepartment of Radiation Oncology, Cleveland Clinic Foundation, Cleveland, OH, USA.
Yesenia GonzalezDepartment of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Jay BurmeisterDepartment of Oncology, Wayne State University School of Medicine, Karmanos Cancer Center, Detroit, MI, USA.
Jeffrey Y C WongDepartment of Radiation Oncology, City of Hope National Medical Center City of Hope National Medical Center, Duarte, CA, USA.
Xuejun GuDepartment of Radiation Oncology, Stanford University, Palo Alto, CA, USA.
Grace Gwe-Ya KimRadiation Medicine and Applied Science, University of California San Diego, La Jolla, CA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We compiled a sampling of the treatment techniques of intensity-modulated total body irradiation, total marrow irradiation and total marrow and lymphoid irradiation utilized by several centers across North America and Europe. This manuscript does not serve as a consensus guideline, but rather is meant to serve as a convenient reference for centers that are considering starting an intensity-modulated program.

Indexed as

Intensity modulationTotal body irradiationTotal marrow irradiation

Identifiers

PMID37753462
PMCPMC10518336

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.